Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001196632-26-000011

Options or other derivatives

  • EVP, Chief Financial Officer disposed of 40,284 shares (code H)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-05-07 Other disposition : show line 1 in the form Employee Stock Option (Right to buy) −19,963 0 D
2026-02-25 Other disposition : show line 2 in the form Employee Stock Option (Right to buy) −20,321 0 D
Loading xslF345X05/wk-form4_1772805051.xml…